A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2006
11/23/2006	US20060263430 instrument for inducing cytokine and method of inducing cytokine
11/23/2006	US20060263429 Compressible mixture, compressed pharmaceutical compositions, and method of preparation thereof
11/23/2006	US20060263428 Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
11/23/2006	US20060263427 Quinine formulations
11/23/2006	US20060263426 Oral administration form for pyridin-2-ylmethysulfinyl-1h-bezimidazoles
11/23/2006	US20060263425 Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
11/23/2006	US20060263424 Pharmaceutical compositions comprising clavulanic acid
11/23/2006	US20060263423 Product and process for increasing compactibility of carbohydrates
11/23/2006	US20060263422 Pharmaceutical composition containing decoy and use of the same
11/23/2006	US20060263417 Electrospun blends of natural and synthetic polymer fibers as tissue engineering scaffolds
11/23/2006	US20060263414 Confectionery products for the treatment of dry mouth
11/23/2006	US20060263413 Delivery system for active components and a material having preselected hydrophobicity as part of an edible composition
11/23/2006	US20060263412 Confectionery products for the treatment of dry mouth
11/23/2006	US20060263409 Treatment of ocular disease
11/23/2006	US20060263401 Packet of spherical particles containing sustained release antibiotic and aqueous solution of thrombin; mixture of biocompatible polymer and gel; in situ wound healing agents
11/23/2006	US20060263397 Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same
11/23/2006	US20060263396 Hand lotion and surgical scrub
11/23/2006	US20060263394 Environmental raw material capable of providing impact resistance, method of producing the same, and moldings
11/23/2006	US20060263393 Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures
11/23/2006	US20060263387 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus
11/23/2006	US20060263361 Pan-kir2dl nk -receptor antibodies and their use in diagnostik and therapy
11/23/2006	US20060263360 Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives
11/23/2006	US20060263347 Lyophilizing an aqueous mixture of a fibrinolytic metalloproteinase, a zinc stabilizer and optionally a bulking agent, in a citric acid or a water soluble citric acid salt buffer and reconstituing said lyophilized composition
11/23/2006	US20060263344 Novel probiotic compositions and methods of using the same
11/23/2006	US20060263329 Antimicrobial polymer compositions and the use thereof
11/23/2006	US20060263327 Method for the production of a stable injectable formulation made of difficult to dissolve antineoplastic active substances
11/23/2006	US20060263322 Cosmetic sheet
11/23/2006	US20060263305 Using azithromycin antibiotic
11/23/2006	US20060263301 In situ gelling self-reactive materials for embolization
11/23/2006	US20060263033 Switchable surfaces
11/23/2006	DE102005023334A1 Propellant-containing aerosol suspension useful for treating diseases e.g. asthma, pain contains active substance with chemically bound water, propellant gas or its mixture
11/23/2006	DE102004054731A1 New pharmaceutical composition comprising an oligonucleotide that is adapted to target nucleic acids encoding CD40, useful for preventing or treating an inflammatory, immune or autoimmune disorder
11/23/2006	CA2651450A1 Anti-cancer medication intended for immunotherapy treatments
11/23/2006	CA2612727A1 Morphine sulfate formulations
11/23/2006	CA2611506A1 Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor
11/23/2006	CA2609000A1 An implantable therapy system for treating a living being with an active factor
11/23/2006	CA2608952A1 Pharmaceutical compostions comprising an amorphous form of a vegf-r inhibitor
11/23/2006	CA2608811A1 Bioresorbable fillers constituted by phospholipid liposomes and hyaluronic acid and/or the derivatives thereof
11/23/2006	CA2608752A1 Formulations for alteration of biophysical properties of mucosal lining
11/23/2006	CA2608690A1 Stable tablet containing droxidopa
11/23/2006	CA2608577A1 Confectionery products for the treatment of dry mouth
11/23/2006	CA2608571A1 Composition for treatment of a detached retina and method of production thereof
11/23/2006	CA2608505A1 Colonic delivery of adsorbents
11/23/2006	CA2608361A1 Morphine sulphate formulations
11/23/2006	CA2608344A1 Method and composition for use in preparation of a patient for surgery
11/23/2006	CA2608273A1 Aerosolized fluoroquinolones and uses thereof
11/23/2006	CA2608185A1 Oral medicament based on a proton pump inhibitors
11/23/2006	CA2607887A1 Methods for fabricating micro-electro-mechanical devices
11/23/2006	CA2607357A1 Inhalator capsules
11/23/2006	CA2607356A1 Extended release tablet
11/23/2006	CA2607319A1 Oil encapsulation
11/23/2006	CA2604568A1 Sustained release l-arginine formulations and methods of manufacture and use
11/23/2006	CA2601800A1 Oral drug delivery system
11/22/2006	EP1724353A2 Methods of forming protein-linked lipidic microparticles
11/22/2006	EP1724339A1 Gene regulation therapy involving ferritin
11/22/2006	EP1723974A1 Collagen gel and process for producing the same
11/22/2006	EP1723966A2 Oil in water emulsion vaccines
11/22/2006	EP1723953A1 Nutritional supplements
11/22/2006	EP1723949A1 Gelified oil particles targeting the sebaceous glands and hair follicles
11/22/2006	EP1723948A1 Controlled release compositions of biguanide with less side effects and treatment regimen thereof
11/22/2006	EP1723929A1 Structures and compositions increasing peroxide actives stability
11/22/2006	EP1723172A1 Erythropoietin liquid formulation
11/22/2006	EP1722884A1 Storage stable multi-microcapsules having adjustable synergitically active functional content components
11/22/2006	EP1722822A1 New complexes
11/22/2006	EP1722821A1 Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same
11/22/2006	EP1722820A1 Long-acting solid formulation comprising triptorelin acetate
11/22/2006	EP1722816A2 Support system in the form of protein-based nanoparticles for the cell-specific enrichment of pharmaceutically active substances
11/22/2006	EP1722802A1 A medical solution, a method for producing said medical solution and use thereof
11/22/2006	EP1722773A1 Pregabalin composition
11/22/2006	EP1722763A2 Plaster that reduces skin irritation
11/22/2006	EP1722762A2 Nanocell drug delivery system
11/22/2006	EP1722761A2 Method of producing microparticles
11/22/2006	EP1722760A2 Delivery of genes encoding short hairpin rna using receptor-specific nanocontainers
11/22/2006	EP1722759A2 Chitosan containing solution
11/22/2006	EP1722758A1 Chronotherapeutic compositions and methods of their use
11/22/2006	EP1722714A1 Biocompatible polymeric delivery systems for sustained release of quinazolinones
11/22/2006	EP1722662A1 A disposable nonwoven mitt
11/22/2006	EP1722645A1 Solubilized coq-10 and carnitine
11/22/2006	EP1722640A1 Liquid supplement compositions comprising one or more medicaments
11/22/2006	EP1480620B1 (ester)-lysolecithins in liposomes
11/22/2006	EP1476196B1 Oral solid solution formulation of a poorly water-soluble active substance
11/22/2006	EP1471893B1 Method and device for producing products in web form
11/22/2006	EP1469826B1 Osmotic delivery system
11/22/2006	EP1459738A4 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties
11/22/2006	EP1438055A4 D-tagatose as an anti-biofilm agent
11/22/2006	EP1432402B1 Compositions for delivery of drug combinations
11/22/2006	EP1427717B1 Bioprecursors for percutaneous application
11/22/2006	EP1415648B1 Lyophilizing composition of drug-encapsulating polymer micelle and method for preparation thereof
11/22/2006	EP1379446B1 Water-soluble container having at least two openings
11/22/2006	EP1343471B1 Microsystem for controlled dispensation of an active substance from a reservoir
11/22/2006	EP1342472B1 Analgesic and anti-inflammatory patches for external use containing 4-biphenylylacetic acid
11/22/2006	EP1315482B1 Water-dispersible encapsulated sterols
11/22/2006	EP1253957B1 Implantable, refillable infusion device
11/22/2006	EP1244401B1 Drug delivery of phase changing formulation
11/22/2006	EP1222033B1 Pore structures for reduced pressure aerosolization
11/22/2006	EP1220682B1 Stabilized liquid polypeptide-containing pharmaceutical compositions
11/22/2006	EP1124540B1 Dosage forms containing taste masked active agents
11/22/2006	EP1054674B1 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
11/22/2006	EP1015570B1 Fibrin microbeads and uses thereof
11/22/2006	EP0952819B1 Biologically active composition

1 ... 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 ... 2991